Work

Ovarian cancer

Year: 2012

Type: article

Abstract: The field of ovarian cancer research has made marked progress in better understanding ovarian cancer and redefining its types. New information is putting into doubt that mutations in KRAS and/or BRAF always portend poor outcome, at least not in low‐grade serous ovarian cancers.

Source: Cancer

DOI: 10.1002/cncr.27833

Authors: Elise C. Kohn, Jean Hurteau

Institutions: National Cancer Institute, Center for Cancer Research, University of Chicago

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute